Definitive Contract HT942523C0011

Award Date 3/8/23
Potential Completion Date 7/7/25
Potential Value $1.1M
Funding Federal Agency
Medical Command
Contracting Federal Agency
Defense Health Agency
Ultimate Awardee
Not listed
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Inglewood, CA 90302, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
The Department of Defense, specifically the Army Medical Command, awarded a $250,000 firm fixed price contract to Critical Innovations LLC of Inglewood, California. The contract is for Phase I of a Small Business Innovation Research proposal related to Department of Defense topic DHA213-009, which involves the development of a wearable wound infection treatment device. The period of performance is from March 25, 2022 through October 24, 2022. The contract has a total small business set aside...
This is a $150,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Army Medical Command (MEDCOM) to Critical Innovations LLC, a small business medical research and development company. The contract is for the SBIR DHP PHASE I PROPOSAL H161-011-0011, which involves the development of innovative solutions for military and pre-hospital healthcare applications. Critical Innovations specializes in advanced medical technologies such as wound treatment, hemorrhage...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Medical Command to Critical Innovations LLC, a small business focused on medical research and development. The $150,000.00 Firm Fixed Price contract is for research under the SBIR program. As a prime contractor, Critical Innovations has previously received over $10 million in SBIR contracts from various military agencies for the development of medical products including devices for wound...
The U.S. Army's Joint PEO Chemical and Biological Defense has awarded a $1,099,999.92 Firm Fixed Price contract to Critical Innovations LLC, a small business medical research and development company, for Phase II of a Small Business Innovation Research (SBIR) program effort. The contract is designated as a total small business set-aside. Critical Innovations will continue development of various advanced medical technologies for military and pre-hospital applications, including solutions for...
This is a $1,100,000.00 Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to Critical Innovations LLC, a small business, under the Small Business Innovation Research (SBIR) program. The contract is for the development of the Pleurapath Thoracostomy System, a medical device for military and pre-hospital healthcare applications. The contract is set to be completed by October 12, 2025. Critical Innovations LLC is a for-profit limited liability company that specializes in...
This contract, awarded by the Defense Health Agency, is a Definitive Contract with a Firm Fixed Price for a Medical Research and Development project under the Army's Small Business Innovation Research (SBIR) Program. The contract, valued at $1,100,000.00, was awarded to Critical Innovations LLC, a for-profit limited liability company that specializes in innovative medical solutions for military and pre-hospital applications. The contract is for the development of the Succor Combat Foam for...
The Department of the Army awarded a $167,499.96 firm-fixed-price Phase I Small Business Innovation Research (SBIR) program contract to Critical Innovations LLC, a limited liability company, for research and development efforts to develop treatments for dermal injuries caused by sulfur mustard. The contract has a total small business set-aside designation. Critical Innovations has previously received over $10 million in SBIR contracts from the Army, Defense Health Agency, and Air Force for...
This contract was awarded by the Defense Health Agency (DHA) to Critical Innovations LLC, a small business medical research and development company, under the Small Business Innovation Research (SBIR) program. The contract, valued at $1,300,000.00, is for the development of the "Donaldson Decompression Needle for Automated Treatment of Tension Pneumothorax" during SBIR Phase II. Critical Innovations specializes in advanced medical technologies for military and pre-hospital...
This is a $162,487.22 Phase I Small Business Innovation Research (SBIR) contract awarded by the Defense Health Agency (DHA) to Innovital Systems Inc., a for-profit small business organization. The contract is for the development of an "Antiseptic, Warming and Pressure Relieving Casualty Transport Pad" under proposal #H191-008-0140. The contract was awarded on July 8, 2019 and has a completion date of February 7, 2020. Innovital Systems is an advanced technology company that has been...
This is a $997,828.73 SBIR Phase II contract awarded by the Defense Health Agency to Innovital Systems Inc., a small business prime contractor, for the development of an intravenous/intubation pilot device to facilitate vascular access. The contract was set aside for small businesses. Innovital Systems is an advanced technology company that has delivered various goods and services to Department of Defense agencies through prime and subcontractor roles, including medical research and development,...

This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Medical Command (MEDCOM) of the Defense Health Agency (DHA) to Critical Innovations LLC, a small business LLC. The $1,100,000.00 contract is for the development of the "RX-Shooter Wearable Wound Infection Treatment Device" under Topic DHA213-009. The award is designated as a total small business set-aside. Critical Innovations is an ISO 13485:2016 certified medical research and development company that has previously received SBIR Phase I, II, and III contracts from various defense agencies for advanced medical technologies related to wound treatment, hemorrhage control, and automated diagnosis and treatment systems. This contract supports the continued research and development of the RX-Shooter device, which is intended to provide critical innovations in the area of wearable wound infection treatment for military and pre-hospital healthcare applications.

Generated 8/16/24, 9:31 AM